bluuebunny/crossref_metadata_2025 huggingface dataset:
Supplementary Figures 1-7 from Host miR155 Promotes Tumor Growth through a Myeloid-Derived Suppressor Cell–Dependent Mechanism
Authors: Chen Siqi , Wang Long , Fan Jie , Ye Cong , Dominguez Donye , Zhang Yi , Curiel Tyler J. , Fang Deyu , Kuzel Timothy M. , Zhang Bin
Published: April 2023

Supplemental Figure 1. Tumor growth in miR-155-deficient mice. Supplemental Figure 2. Host miR-155 deficiency enhanced antigen-specific antitumor T cell immunity. Supplemental Figure 3. miR-155 is required for optimal function of DCs and T cells from tumor-bearing mice. Supplemental Figure 4. miR-155 is required for splenic MDSC accumulation in different tumor models. Supplemental Figure 5. miR-155 regulates BM-derived MDSC. Supplemental Figure 6. Decreased accumulation of Tregs in miR-155- deficient tumor-bearing mice. Supplemental Figure 7. Suppressive activity and tumor-promoting role of miR-155-deficient Tregs.
Supplementary Figure S1 from Bortezomib Improves Adoptive T-cell Therapy by Sensitizing Cancer Cells to FasL Cytotoxicity
Authors: Shanker Anil , Pellom Samuel T. , Dudimah Duafalia F. , Thounaojam Menaka C. , de Kluyver Rachel L. , Brooks Alan D. , Yagita Hideo , McVicar Daniel W. , Murphy William J. , Longo Dan L. , Sayers Thomas J.
Published: April 2023

Increase in the number of lung metastases following the suppressive regimen of bortezomib.
Supplementary Figure S2 from Targeting a Plk1-Controlled Polarity Checkpoint in Therapy-Resistant Glioblastoma-Propagating Cells
Authors: Lerner Robin G. , Grossauer Stefan , Kadkhodaei Banafsheh , Meyers Ian , Sidorov Maxim , Koeck Katharina , Hashizume Rintaro , Ozawa Tomoko , Phillips Joanna J. , Berger Mitchel S. , Nicolaides Theodore , James C. David , Petritsch Claudia K.
Published: April 2023

CD133+ and CD133-/NG2+ subpopulations with distinct viability in GBM cell lines.
Supplemental material and method from Membrane IL1α Inhibits the Development of Hepatocellular Carcinoma via Promoting T- and NK-cell Activation
Authors: Lin Dandan , Lei Lei , Liu Yonghao , Zhang Yinsheng , Hu Bo , Bao Guangming , Song Yuan , Jin Ziqi , Liu Chunliang , Mei Yu , Sandikin Dedy , Wu Yan , Zhao Lixiang , Yu Xiao , Liu Haiyan
Published: April 2023

Supplemental material and methods
Supplemental figure legends from Membrane IL1α Inhibits the Development of Hepatocellular Carcinoma via Promoting T- and NK-cell Activation
Authors: Lin Dandan , Lei Lei , Liu Yonghao , Zhang Yinsheng , Hu Bo , Bao Guangming , Song Yuan , Jin Ziqi , Liu Chunliang , Mei Yu , Sandikin Dedy , Wu Yan , Zhao Lixiang , Yu Xiao , Liu Haiyan
Published: April 2023

Supplemental figure legends
Supplemental Figure 1 from Membrane IL1α Inhibits the Development of Hepatocellular Carcinoma via Promoting T- and NK-cell Activation
Authors: Lin Dandan , Lei Lei , Liu Yonghao , Zhang Yinsheng , Hu Bo , Bao Guangming , Song Yuan , Jin Ziqi , Liu Chunliang , Mei Yu , Sandikin Dedy , Wu Yan , Zhao Lixiang , Yu Xiao , Liu Haiyan
Published: April 2023

Supplemental Figure 1 IL-1R1 expression and tumor-specific activation of T cells in vitro.
Supplementary Materials and Methods from Generation of a Mouse Model of Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System through Combined Deletion of Snf5 and p53
Authors: Ng Jessica M.Y. , Martinez Daniel , Marsh Eric D. , Zhang Zhe , Rappaport Eric , Santi Mariarita , Curran Tom
Published: April 2023

Description of additional methods and procedures used in the study.
Supplementary Table S1 from CLK2 Is an Oncogenic Kinase and Splicing Regulator in Breast Cancer
Authors: Yoshida Taku , Kim Jee Hyun , Carver Kristopher , Su Ying , Weremowicz Stanislawa , Mulvey Laura , Yamamoto Shoji , Brennan Cameron , Mei Shenglin , Long Henry , Yao Jun , Polyak Kornelia
Published: April 2023

Supplementary Table S1. Kinases with copy number gain and overexpression in breast cancer tested in shRNA screen.
Supplemental Figure S2 from Generation of a Mouse Model of Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System through Combined Deletion of Snf5 and p53
Authors: Ng Jessica M.Y. , Martinez Daniel , Marsh Eric D. , Zhang Zhe , Rappaport Eric , Santi Mariarita , Curran Tom
Published: April 2023

Snf5/Baf47 expression in Snf5F/F p53L/L GFAP-Cre mutant brain tissue.
Supplemental Figure S1 from Generation of a Mouse Model of Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System through Combined Deletion of Snf5 and p53
Authors: Ng Jessica M.Y. , Martinez Daniel , Marsh Eric D. , Zhang Zhe , Rappaport Eric , Santi Mariarita , Curran Tom
Published: April 2023

Snf5 inactivation causes neurodegeneration.
Supplementary Tables S1-S8, Figures S1-S4 from Whole-Exome Sequencing Reveals Frequent Genetic Alterations in BAP1, NF2, CDKN2A, and CUL1 in Malignant Pleural Mesothelioma
Authors: Guo Guangwu , Chmielecki Juliann , Goparaju Chandra , Heguy Adriana , Dolgalev Igor , Carbone Michele , Seepo Sara , Meyerson Matthew , Pass Harvey I.
Published: April 2023

Supplementary Tables S1-S8, Figures S1-S4. Table S1. Clinical characteristics of the 22 MPM patients. Table S2. Primer sequences of PIK3C2B, RDX, and TAOK1 for validation experiment. Table S3. A list of all somatic mutations detected in 22 MPMs (shown in separate excel file). Table S4. The average mutation rates of different cancer types in previously reported cancer genome studies. Table S5. Recurrently mutated genes that harbored much higher mutations than the background with significant threshold of P <0.01. Table S6. List of significant focal copy number alterations in the 22 MPMs (shown in separate excel file). Table S7. Pathways that are significantly enriched with genetic alterations in MPM. Table S8. Somatic mutations in the genes of Hippo signaling pathway(12) in MPMs. Figure S1. Spectrum of somatic point mutations identified in the 22 MPMs. Figure S2. Copy number alteration profiles of 22 MPMs using the whole exome sequencing data. Figure S3. Statistically significant focal deletions (blue) plotted along the genome for the MPM. Figure S4. A significant region of focal deletion at 9p21 containing CDKN2A/B and MIR31 (microRNA 31) in MPM rendered by the Integrative Genomics Viewer (IGV).
Table S1 from Disseminated Tumor Cells Persist in the Bone Marrow of Breast Cancer Patients through Sustained Activation of the Unfolded Protein Response
Authors: Bartkowiak Kai , Kwiatkowski Marcel , Buck Friedrich , Gorges Tobias M. , Nilse Lars , Assmann Volker , Andreas Antje , Müller Volkmar , Wikman Harriet , Riethdorf Sabine , Schlüter Hartmut , Pantel Klaus
Published: April 2023

Summary of the differentially expressed protein between BC-M1 and MDA-MB-468
Supplementary Figure Legends from SND1 Acts Downstream of TGFβ1 and Upstream of Smurf1 to Promote Breast Cancer Metastasis
Authors: Yu Lin , Liu Xin , Cui Kang , Di Yanbo , Xin Lingbiao , Sun Xiaoming , Zhang Wei , Yang Xi , Wei Minxin , Yao Zhi , Yang Jie
Published: April 2023

Supplementary Figure Legends. Legends for Supplementary Figures S1-S2.
Supplemental Figure 3 from Glioblastomas Require Integrin αvβ3/PAK4 Signaling to Escape Senescence
Authors: Franovic Aleksandra , Elliott Kathryn C. , Seguin Laetitia , Camargo M. Fernanda , Weis Sara M. , Cheresh David A.
Published: April 2023

Requirement for integrin ligand binding function
Supplemental Figure 1 from Glioblastomas Require Integrin αvβ3/PAK4 Signaling to Escape Senescence
Authors: Franovic Aleksandra , Elliott Kathryn C. , Seguin Laetitia , Camargo M. Fernanda , Weis Sara M. , Cheresh David A.
Published: April 2023

Confirmation of knockdown efficiency
Supplementary Materials and Methods from Exploring the Biomechanical Properties of Brain Malignancies and Their Pathologic Determinants In Vivo with Magnetic Resonance Elastography
Authors: Jamin Yann , Boult Jessica K.R. , Li Jin , Popov Sergey , Garteiser Philippe , Ulloa Jose L. , Cummings Craig , Box Gary , Eccles Suzanne A. , Jones Chris , Waterton John C. , Bamber Jeffrey C. , Sinkus Ralph , Robinson Simon P.
Published: April 2023

Supplementary Materials and Methods. Description of additional methods and procedures used in the study.
Supplementary Figure S11 from Identification of Patients with Recurrent Glioblastoma Who May Benefit from Combined Bevacizumab and CCNU Therapy: A Report from the BELOB Trial
Authors: Erdem-Eraslan Lale , van den Bent Martin J. , Hoogstrate Youri , Naz-Khan Hina , Stubbs Andrew , van der Spek Peter , Böttcher René , Gao Ya , de Wit Maurice , Taal Walter , Oosterkamp Hendrika M. , Walenkamp Annemiek , Beerepoot Laurens V. , Hanse Monique C.J. , Buter Jan , Honkoop Aafke H. , van der Holt Bronno , Vernhout René M. , Smitt Peter A.E. Sillevis , Kros Johan M. , French Pim J.
Published: April 2023

Examples of two genes where introns are spliced out prior to transcription of the entire intron.
Supplementary Figure S6 from Obesity-Induced Colorectal Cancer Is Driven by Caloric Silencing of the Guanylin–GUCY2C Paracrine Signaling Axis
Authors: Lin Jieru E. , Colon-Gonzalez Francheska , Blomain Erik , Kim Gilbert W. , Aing Amanda , Stoecker Brian , Rock Justin , Snook Adam E. , Zhan Tingting , Hyslop Terry M. , Tomczak Michal , Blumberg Richard S. , Waldman Scott A.
Published: April 2023

Daily calorie intake, body weights, and guanylin expression in Ob/Ob mice on ad libitum or calorie-restricted diets.
Supplementary Figure S4 from Candidate Antimetastasis Drugs Suppress the Metastatic Capacity of Breast Cancer Cells by Reducing Membrane Fluidity
Authors: Zhao Weina , Prijic Sara , Urban Bettina C. , Tisza Michael J. , Zuo Yan , Li Lin , Tan Zhi , Chen Xiaoling , Mani Sendurai A. , Chang Jeffrey T.
Published: April 2023

ABCA1 is required for metastatic phenotypes in vitro.
Supplementary Figure S3 from Candidate Antimetastasis Drugs Suppress the Metastatic Capacity of Breast Cancer Cells by Reducing Membrane Fluidity
Authors: Zhao Weina , Prijic Sara , Urban Bettina C. , Tisza Michael J. , Zuo Yan , Li Lin , Tan Zhi , Chen Xiaoling , Mani Sendurai A. , Chang Jeffrey T.
Published: April 2023

Drugs alter plasma membrane fluidity across cell lines and growth conditions, associated with changes in metastatic phenotypes.
supplementary figure and table legends from Comparative Cistromics Reveals Genomic Cross-talk between FOXA1 and ERα in Tamoxifen-Associated Endometrial Carcinomas
Authors: Droog Marjolein , Nevedomskaya Ekaterina , Kim Yongsoo , Severson Tesa , Flach Koen D. , Opdam Mark , Schuurman Karianne , Gradowska Patrycja , Hauptmann Michael , Dackus Gwen , Hollema Harry , Mourits Marian J. , Nederlof Petra , van Boven Hester , Linn Sabine C. , Wessels Lodewyk , van Leeuwen Flora E. , Zwart Wilbert
Published: April 2023

legends to supplementary tables and figures
Supplementary Table 1 from Activation of Hematopoietic Stem/Progenitor Cells Promotes Immunosuppression Within the Pre–metastatic Niche
Authors: Giles Amber Jin , Reid Caitlin Marie , Evans Justin DeWayne , Murgai Meera , Vicioso Yorleny , Highfill Steven Lorenz , Kasai Miki , Vahdat Linda , Mackall Crystal Lee , Lyden David , Wexler Leonard , Kaplan Rosandra Natasha
Published: April 2023

Cytokines produced in tumor-conditioned media.
Figure S2 from Comparative Cistromics Reveals Genomic Cross-talk between FOXA1 and ERα in Tamoxifen-Associated Endometrial Carcinomas
Authors: Droog Marjolein , Nevedomskaya Ekaterina , Kim Yongsoo , Severson Tesa , Flach Koen D. , Opdam Mark , Schuurman Karianne , Gradowska Patrycja , Hauptmann Michael , Dackus Gwen , Hollema Harry , Mourits Marian J. , Nederlof Petra , van Boven Hester , Linn Sabine C. , Wessels Lodewyk , van Leeuwen Flora E. , Zwart Wilbert
Published: April 2023

ChIP-QPCR validation of ChIP-seq peaks found in endometrial cancer specimens.
Supplementary Tables 1 through 3 from p53 Loss in MYC-Driven Neuroblastoma Leads to Metabolic Adaptations Supporting Radioresistance
Authors: Yogev Orli , Barker Karen , Sikka Arti , Almeida Gilberto S. , Hallsworth Albert , Smith Laura M. , Jamin Yann , Ruddle Ruth , Koers Alexander , Webber Hannah T. , Raynaud Florence I. , Popov Sergey , Jones Chris , Petrie Kevin , Robinson Simon P. , Keun Hector C. , Chesler Louis
Published: April 2023

Supplementary Table 1. Median latency, penetration, tumor characteristics for Th-MYCN/Trp53WT/WT, Th-MYCN/Trp53KI/WT and Th-MYCN/Trp53KI/KI mice. Supplementary Table 2. Sequencing results for Trp53 exons 5-9. Supplementary Table 3. KEGG pathway analysis of genes differentially expressed in Th-MYCN/Trp53KI/KI tumors versus Th-MYCN/Trp53WT/WT tumors
Supplementary Figures and Tables from TMEM2 Is a SOX4-Regulated Gene That Mediates Metastatic Migration and Invasion in Breast Cancer
Authors: Lee Hyeseung , Goodarzi Hani , Tavazoie Sohail F. , Alarcón Claudio R.
Published: April 2023

Supplementary Figure S1 contains TMEM2 protein expression levels in human cancer. Supplementary Figure S2 contains quantification of mRNA levels of TMEM2 in the context of SOX4 knockdown or overexpression. Supplementary Figure S3 contains western blot quantification of TMEM2 in the TMEM2 knockdown cells. Supplementary Figure S4 contains the result of in vivo lung colonization assay done in CN34-LM1A cells with TMEM2 knockdown by an independent shRNA. Supplementary Table S1 contains primer information used in this study. Supplementary Table S2, S3, and S4 contain list of genes from each steps of systematic analyses done in this study.
Supplementary Figure 7 from Galectin-3 Cleavage Alters Bone Remodeling: Different Outcomes in Breast and Prostate Cancer Skeletal Metastasis
Authors: Nakajima Kosei , Kho Dhong Hyo , Yanagawa Takashi , Harazono Yosuke , Hogan Victor , Chen Wei , Ali-Fehmi Rouba , Mehra Rohit , Raz Avraham
Published: April 2023

Results of immunohistochemistry in breast and prostate cancer patients with metastasis.
Supplementary information from Antagonizing Integrin β3 Increases Immunosuppression in Cancer
Authors: Su Xinming , Esser Alison K. , Amend Sarah R. , Xiang Jingyu , Xu Yalin , Ross Michael H. , Fox Gregory C. , Kobayashi Takayuki , Steri Veronica , Roomp Kirsten , Fontana Francesca , Hurchla Michelle A. , Knolhoff Brett L. , Meyer Melissa A. , Morgan Elizabeth A. , Tomasson Julia C. , Novack Joshua S. , Zou Wei , Faccio Roberta , Novack Deborah V. , Robinson Stephen D. , Teitelbaum Steven L. , DeNardo David G. , Schneider Jochen G. , Weilbaecher Katherine N.
Published: April 2023

Supplementary methods and figure legends
Supplementary Figure S10 from Comprehensive Ex Vivo Transposon Mutagenesis Identifies Genes That Promote Growth Factor Independence and Leukemogenesis
Authors: Guo Yabin , Updegraff Barrett L. , Park Sunho , Durakoglugil Deniz , Cruz Victoria H. , Maddux Sarah , Hwang Tae Hyun , O'Donnell Kathryn A.
Published: April 2023

Phosphorylation of STAT5 in Ba/F3 cells overexpressing CIS genes.
Supplemental Experimental Procedures from The Beta Subunit of Hemoglobin (HBB2/HBB) Suppresses Neuroblastoma Growth and Metastasis
Authors: Maman Shelly , Sagi-Assif Orit , Yuan Weirong , Ginat Ravit , Meshel Tsipi , Zubrilov Inna , Keisari Yona , Lu Weiyue , Lu Wuyuan , Witz Isaac P.
Published: April 2023

This file includes supplemental experimental procedures. It includes a description of animals, antibodies, dialysis of lung-derived factors, in-vitro viability assays, blocking the inhibitory effect of lung-derived factors, quantitative Real-Time PCR, fixation and sectioning of frozen tissues, immunofluorescence of frozen tissue sections, protein extraction from mouse organs, western blotting, enzyme-Linked Immunosorbent assay, Isolation of primary endothelial and epithelial cells from mouse lungs, Incubation of HPF and HPEC with MicroNB cells in Transwell system, apoptosis assay, cell cycle analysis, ERK1/2, p38 and TAK1 phosphorylation, Solid-phase synthesis of human HBB segments, Conjugation of Metox peptide to FITC, Confocal microscopy for Metox cell entry, Flow cytometry for Metox cell entry, orthotopic inoculation of tumor cells, monitoring tumor growth and metastasis, RNA preparation and Reverse Transcription Polymerase Chain Reaction, quantitative real-time PCR, intravenous and intranasal treatment of Metox, hemolytic assay, and nitric oxide assay.
CTL CD103+ on rICAM-Fc from TGFβ Signaling Intersects with CD103 Integrin Signaling to Promote T-Lymphocyte Accumulation and Antitumor Activity in the Lung Tumor Microenvironment
Authors: Boutet Marie , Gauthier Ludiane , Leclerc Marine , Gros Gwendoline , de Montpreville Vincent , Théret Nathalie , Donnadieu Emmanuel , Mami-Chouaib Fathia
Published: April 2023

CTL CD103+ on rICAM-Fc from TGFβ Signaling Intersects with CD103 Integrin Signaling to Promote T-Lymphocyte Accumulation and Antitumor Activity in the Lung Tumor Microenvironment
Supplementary Figure 5 from Myeloid-Derived Suppressor Cells Endow Stem-like Qualities to Breast Cancer Cells through IL6/STAT3 and NO/NOTCH Cross-talk Signaling
Authors: Peng Dongjun , Tanikawa Takashi , Li Wei , Zhao Lili , Vatan Linda , Szeliga Wojciech , Wan Shanshan , Wei Shuang , Wang Yin , Liu Yan , Staroslawska Elzbieta , Szubstarski Franciszek , Rolinski Jacek , Grywalska Ewelina , Stanisławek Andrzej , Polkowski Wojciech , Kurylcio Andrzej , Kleer Celina , Chang Alfred E. , Wicha Max , Sabel Michael , Zou Weiping , Kryczek Ilona
Published: April 2023

Correlations between CD33, ALDH1A1 and IL6 transcripts in patients with breast cancer
Supplementary Figure Legends from Ubiquitin-Specific Protease 4-Mediated Deubiquitination and Stabilization of PRL-3 Is Required for Potentiating Colorectal Oncogenesis
Authors: Xing Cheng , Lu Xing-Xing , Guo Peng-Da , Shen Tong , Zhang Shen , He Xiao-Shun , Gan Wen-Juan , Li Xiu-Ming , Wang Jing-Ru , Zhao Yuan-Yuan , Wu Hua , Li Jian-Ming
Published: April 2023

Legends for Supplementary Figures S1-S8.
Supplementary Table 3 from An Anti-EGFR IgA That Displays Improved Pharmacokinetics and Myeloid Effector Cell Engagement In Vivo
Authors: Lohse Stefan , Meyer Saskia , Meulenbroek Laura A.P.M. , Jansen J.H. Marco , Nederend Maaike , Kretschmer Anna , Klausz Katja , Möginger Uwe , Derer Stefanie , Rösner Thies , Kellner Christian , Schewe Denis , Sondermann Peter , Tiwari Sanjay , Kolarich Daniel , Peipp Matthias , Leusen Jeanette H.W. , Valerius Thomas
Published: April 2023

Relative Quantitation of N-glycan structures.
Supplementary Table 1 from An Anti-EGFR IgA That Displays Improved Pharmacokinetics and Myeloid Effector Cell Engagement In Vivo
Authors: Lohse Stefan , Meyer Saskia , Meulenbroek Laura A.P.M. , Jansen J.H. Marco , Nederend Maaike , Kretschmer Anna , Klausz Katja , Möginger Uwe , Derer Stefanie , Rösner Thies , Kellner Christian , Schewe Denis , Sondermann Peter , Tiwari Sanjay , Kolarich Daniel , Peipp Matthias , Leusen Jeanette H.W. , Valerius Thomas
Published: April 2023

Iontrap aquisition Settings according to MIRAGE Guidelines.
Supplemental Fig.S2. from HEATR1 Negatively Regulates Akt to Help Sensitize Pancreatic Cancer Cells to Chemotherapy
Authors: Liu Tongzheng , Fang Yuan , Zhang Haoxing , Deng Min , Gao Bowen , Niu Nifang , Yu Jia , Lee SeungBaek , Kim JungJin , Qin Bo , Xie Fang , Evans Debra , Wang Liewei , Lou Wenhui , Lou Zhenkun
Published: April 2023

Supplemental Fig.S2. HEATR1 regulates cancer cell response to chemotherapy and cell growth
Supplementary Material from An Anti-EGFR IgA That Displays Improved Pharmacokinetics and Myeloid Effector Cell Engagement In Vivo
Authors: Lohse Stefan , Meyer Saskia , Meulenbroek Laura A.P.M. , Jansen J.H. Marco , Nederend Maaike , Kretschmer Anna , Klausz Katja , Möginger Uwe , Derer Stefanie , Rösner Thies , Kellner Christian , Schewe Denis , Sondermann Peter , Tiwari Sanjay , Kolarich Daniel , Peipp Matthias , Leusen Jeanette H.W. , Valerius Thomas
Published: April 2023

Material and Methods Glycoprofiling
Supplementary Figure 1 from An Anti-EGFR IgA That Displays Improved Pharmacokinetics and Myeloid Effector Cell Engagement In Vivo
Authors: Lohse Stefan , Meyer Saskia , Meulenbroek Laura A.P.M. , Jansen J.H. Marco , Nederend Maaike , Kretschmer Anna , Klausz Katja , Möginger Uwe , Derer Stefanie , Rösner Thies , Kellner Christian , Schewe Denis , Sondermann Peter , Tiwari Sanjay , Kolarich Daniel , Peipp Matthias , Leusen Jeanette H.W. , Valerius Thomas
Published: April 2023

SDS-PAGE separated and electroblotted IgA Proteins after staining with direct blue 71. The red boxes indicate the bands cut out for subsequent N-glycan Analysis.
Supplemental Fig.S.3 from HEATR1 Negatively Regulates Akt to Help Sensitize Pancreatic Cancer Cells to Chemotherapy
Authors: Liu Tongzheng , Fang Yuan , Zhang Haoxing , Deng Min , Gao Bowen , Niu Nifang , Yu Jia , Lee SeungBaek , Kim JungJin , Qin Bo , Xie Fang , Evans Debra , Wang Liewei , Lou Wenhui , Lou Zhenkun
Published: April 2023

HEATR1 colocalized with Akt and regulates Akt phosphorylation independent of PDK1
Supplementary Figure S6 from Chemotherapy-Induced miRNA-29c/Catenin-δ Signaling Suppresses Metastasis in Gastric Cancer
Authors: Wang Yuxuan , Liu Changzheng , Luo Min , Zhang Zhengyi , Gong Jianan , Li Jingjing , You Lei , Dong Lei , Su Rui , Lin Haishuang , Ma Yanni , Wang Fang , Wang Yi , Chen Jie , Zhang Junwu , Jia Hongyan , Kong Yan , Yu Jia
Published: April 2023

Supplementary Figure S6. miR-29s and catenin-ÃŽ' expression depicts an inverse correlation in 20 cases of GC tissues.
Supplemental Materials and Methods from Combined Inhibition of DNMT and HDAC Blocks the Tumorigenicity of Cancer Stem-like Cells and Attenuates Mammary Tumor Growth
Authors: Pathania Rajneesh , Ramachandran Sabarish , Mariappan Gurusamy , Thakur Priyanka , Shi Huidong , Choi Jeong-Hyeon , Manicassamy Santhakumar , Kolhe Ravindra , Prasad Puttur D. , Sharma Suash , Lokeshwar Bal L. , Ganapathy Vadivel , Thangaraju Muthusamy
Published: April 2023

The Supplemental materials and method file has methods for the Generation of mammospheres and tumorospheres, Preparation of single cell suspension from mammary gland, methods for RNA Isolation and Real-time PCR, and Clonogenic assay.
Supplementary Figure S2 from Chemotherapy-Induced miRNA-29c/Catenin-δ Signaling Suppresses Metastasis in Gastric Cancer
Authors: Wang Yuxuan , Liu Changzheng , Luo Min , Zhang Zhengyi , Gong Jianan , Li Jingjing , You Lei , Dong Lei , Su Rui , Lin Haishuang , Ma Yanni , Wang Fang , Wang Yi , Chen Jie , Zhang Junwu , Jia Hongyan , Kong Yan , Yu Jia
Published: April 2023

Supplementary Figure S2. Correlations between miR-29s levels and histological grade of GCs.
Supplementary Figure S1 from Chemotherapy-Induced miRNA-29c/Catenin-δ Signaling Suppresses Metastasis in Gastric Cancer
Authors: Wang Yuxuan , Liu Changzheng , Luo Min , Zhang Zhengyi , Gong Jianan , Li Jingjing , You Lei , Dong Lei , Su Rui , Lin Haishuang , Ma Yanni , Wang Fang , Wang Yi , Chen Jie , Zhang Junwu , Jia Hongyan , Kong Yan , Yu Jia
Published: April 2023

Supplementary Figure S1. miR-29s expression analyses in GC cells.
Supplemental Material and Methods from Agonists of the TRAIL Death Receptor DR5 Sensitize Intestinal Stem Cells to Chemotherapy-Induced Cell Death and Trigger Gastrointestinal Toxicity
Authors: Finnberg Niklas K. , Gokare Prashanth , Navaraj Arunasalam , Lang Kuhs Krystle A. , Cerniglia George , Yagita Hideo , Takeda Kazuyoshi , Motoyama Noboru , El-Deiry Wafik S.
Published: April 2023

Supplemental Material & Methods
Supplementary Figures S1-S8 from Improved Treatment of Breast Cancer with Anti-HER2 Therapy Requires Interleukin-21 Signaling in CD8+ T Cells
Authors: Mittal Deepak , Caramia Franco , Michiels Stefan , Joensuu Heikki , Kellokumpu-Lehtinen Pirkko-Liisa , Sotiriou Christos , Loi Sherene , Smyth Mark J.
Published: April 2023

IL-21R expression on splenocytes and TILs from H2N100 tumor-bearing mice (S1); ErbB-2 positive tumor cell lines do not express IL-21R (S2); CD8+ T cells and NK cells after ACT in Balb/c.Rag2-/- γc-/- mice (S3); B-cells and NKT cells are not likely to be required for anti-ErbB-2 mAb therapy (S4); Tfh cells are not likely to be required for anti-ErbB-2 mAb therapy (S5); Myeloid cell infiltrates in ErbB-2+ tumors (S6); Recombinant IL-21 improves therapeutic efficacy of anti-ErbB-2 mAb therapy (S7); Spearmans' correlations are shown between genes of interest, TILs as previously described and selected genes representing CD8+ T cell phenotype using patient's samples from the FinHER clinical trial (S8).
Supplementary Table S9 from Transcriptome Analysis of Recurrently Deregulated Genes across Multiple Cancers Identifies New Pan-Cancer Biomarkers
Authors: Kaczkowski Bogumil , Tanaka Yuji , Kawaji Hideya , Sandelin Albin , Andersson Robin , Itoh Masayoshi , Lassmann Timo , Hayashizaki Yoshihide , Carninci Piero , Forrest Alistair R.R.
Published: April 2023

Gene level overlap between differentially expressed, protein-coding genes from the FANTOM5 analysis, the TCGA in-house analysis and the TCGA analysis by Cabanski at al. and Zhang at al.
Supplementary Table S6 from Transcriptome Analysis of Recurrently Deregulated Genes across Multiple Cancers Identifies New Pan-Cancer Biomarkers
Authors: Kaczkowski Bogumil , Tanaka Yuji , Kawaji Hideya , Sandelin Albin , Andersson Robin , Itoh Masayoshi , Lassmann Timo , Hayashizaki Yoshihide , Carninci Piero , Forrest Alistair R.R.
Published: April 2023

ChIA-PET associations between differentially expressed enhancerRNAs (eRNAs) and promoters of annotated genes.
Supplementary Table S4 from Transcriptome Analysis of Recurrently Deregulated Genes across Multiple Cancers Identifies New Pan-Cancer Biomarkers
Authors: Kaczkowski Bogumil , Tanaka Yuji , Kawaji Hideya , Sandelin Albin , Andersson Robin , Itoh Masayoshi , Lassmann Timo , Hayashizaki Yoshihide , Carninci Piero , Forrest Alistair R.R.
Published: April 2023

The list of genes differentially expressed in TCGAs primary tumors vs. normal tissues.
Supplementary Table S2 from Transcriptome Analysis of Recurrently Deregulated Genes across Multiple Cancers Identifies New Pan-Cancer Biomarkers
Authors: Kaczkowski Bogumil , Tanaka Yuji , Kawaji Hideya , Sandelin Albin , Andersson Robin , Itoh Masayoshi , Lassmann Timo , Hayashizaki Yoshihide , Carninci Piero , Forrest Alistair R.R.
Published: April 2023

Results of promoter level Differential Expression Analysis by EdgeR.
Figure S9: Loss of RhoB activity increases YAP nuclear localization. from RASSF1A Suppresses the Invasion and Metastatic Potential of Human Non–Small Cell Lung Cancer Cells by Inhibiting YAP Activation through the GEF-H1/RhoB Pathway
Authors: Dubois Fatéméh , Keller Maureen , Calvayrac Olivier , Soncin Fabrice , Hoa Lily , Hergovich Alexander , Parrini Maria-Carla , Mazières Julien , Vaisse-Lesteven Mélissa , Camonis Jacques , Levallet Guénaëlle , Zalcman Gérard
Published: April 2023

HBEC-3 cells were transiently transfected with siNeg or siRASSF1A-1 in combination or not with siRhoB A) The invasion capacity was assessed using a BioCoat Matrigel Invasion Chamber. The relative invasion was normalized to that of the cells transfected with siNeg. B) Quantification of nuclear localization of Yap by immunofluorescence and confocal microscopy. The cells stained by Yap primary antibody (Green) followed by Alexa488 conjugated secondary antibody along with DAPI for DNA (Blue). Scale bar represents 50 µm. For all of the histograms, error bars indicate the standard error of the mean (SEM) of at least three independent experiments. *p<0.05, **p<0.01 and ***p<0.001, using an ANOVA test followed by Dunnett's test.
Supplementary Figures 1 through 7, Supplementary Tables 1 through 9 from Combined MYC Activation and Pten Loss Are Sufficient to Create Genomic Instability and Lethal Metastatic Prostate Cancer
Authors: Hubbard Gretchen K. , Mutton Laura N. , Khalili May , McMullin Ryan P. , Hicks Jessica L. , Bianchi-Frias Daniella , Horn Lucas A. , Kulac Ibrahim , Moubarek Michael S. , Nelson Peter S. , Yegnasubramanian Srinivasan , De Marzo Angelo M. , Bieberich Charles J.
Published: April 2023

Supplementary Figure 1 Morphology of PIN in B13-MYC mice. Supplementary Figure 2 Phenotypic analysis of PIN in a B13-MYC mouse (ventral lobe, 52 weeks old). Supplementary Figure 3 Additional phenotypic analysis of B-MYC/Pten mouse PIN (anterior lobe, 8 weeks). Supplementary Figure 4 Invasive adenocarcinoma lesion in a 14 week old B-MYC/Pten animal. Supplementary Figure 5 Chromogranin (a) staining in a primary tumor and Foxa2 (b) staining in a lymph node metastasis from a 24 week-old B-MYC/Pten animal shows focal scattered tumor cells staining positively (arrows). Supplementary Figure 6 Morphological features of castrated B-MYC/Pten animals. Supplementary Figure 7. Genes within regions of copy number gains and losses are enriched in specific gene ontology (GO) gene sets. Supplementary Table 1. Prostate Phenotype in B-MYC/PtenFl/Fl mice and wild type (FVB/N) mice. Supplementary Table 2. Metastatic Spread in B-MYC/PtenFl/Fl mice and wild type (FVB/N) mice. Supplementary Table 3. Prostate Phenotype in B-MYC/PtenFl/+ mice and wild type mice. Supplementary Table 4. Effects of androgen withdrawal/castration in B-MYC/PtenFl/Fl mice and wild type (FVB/N) mice. Supplementary Table 5. Metastatic Spread in B-MYC/PtenFl/Fl mice after androgen withdrawal. Supplementary Table 6. Somatic copy number gains and losses in each sample. Supplementary Table 7. Regions of Copy Number alterations in each sample. Supplementary Table 8. Regions with recurrent gains and losses in at least two mice. Supplementary Table 9. Regions of high copy number gain and low copy number loss in any tumor specimen.
Figure S5. RASSF1A depletion reduces focal adhesion proteins and adhesion capacities in vitro. from RASSF1A Suppresses the Invasion and Metastatic Potential of Human Non–Small Cell Lung Cancer Cells by Inhibiting YAP Activation through the GEF-H1/RhoB Pathway
Authors: Dubois Fatéméh , Keller Maureen , Calvayrac Olivier , Soncin Fabrice , Hoa Lily , Hergovich Alexander , Parrini Maria-Carla , Mazières Julien , Vaisse-Lesteven Mélissa , Camonis Jacques , Levallet Guénaëlle , Zalcman Gérard
Published: April 2023

The HBEC-3 cells were transiently transfected with siNeg, si RASSF1A or siRASSF1AC. The experiences were performed 48 hours after transfection. A. Expression of focal adhesion complex proteins was examined by RT-PCR analysis. B & C. Adhesion strength of the HBEC-3 cells on fibronectin (B) and laminin (C). For all of the histograms, error bars indicate the standard error of the mean (SEM) of at least three independent experiments. *p<0.05, **p<0.01 and ***p<0.001, using an ANNOVA test followed by Dunnett's test.
Figure S1: Scheme of RASSF1 splicing isoforms and localization annealing regions of siRNAs and shRNAs used. from RASSF1A Suppresses the Invasion and Metastatic Potential of Human Non–Small Cell Lung Cancer Cells by Inhibiting YAP Activation through the GEF-H1/RhoB Pathway
Authors: Dubois Fatéméh , Keller Maureen , Calvayrac Olivier , Soncin Fabrice , Hoa Lily , Hergovich Alexander , Parrini Maria-Carla , Mazières Julien , Vaisse-Lesteven Mélissa , Camonis Jacques , Levallet Guénaëlle , Zalcman Gérard
Published: April 2023

RASSF1 eight coding exon regions are represented along with the eight different transcripts arising from alternative splicing with the use of two different promoters. Only siRASSF1A and shRASSF1A-777, by annealing to 1alpha exon are able to deplete the mRNA species transcribed from the first promoter proceeding 1alpha(RASSF1A, D, E , F, G, H), whereas siRASSF1AC and shRASSF1A-779, by annealing to exon 4 or 4-5 respectively, are able to deplete all species, since they all contain exon 4. The 737 bp CpG island methylated in human cancers spans the first promoter for RASSF1A, D, E, F, G, H.
Supplemental Figure S4 from Autocrine Secretion of Progastrin Promotes the Survival and Self-Renewal of Colon Cancer Stem–like Cells
Authors: Giraud Julie , Failla Laura M. , Pascussi Jean-Marc , Lagerqvist Ebba L. , Ollier Jérémy , Finetti Pascal , Bertucci François , Ya Chu , Gasmi Imène , Bourgaux Jean-François , Prudhomme Michel , Mazard Thibault , Ait-Arsa Imade , Houhou Leila , Birnbaum Daniel , Pélegrin André , Vincent Charles , Ryall James G. , Joubert Dominique , Pannequin Julie , Hollande Frédéric
Published: April 2023

shRNA-mediated down regulation of progastrin in vitro and in vivo.
Supplementary Figure Legends from Aberrant Activation of Notch Signaling Inhibits PROX1 Activity to Enhance the Malignant Behavior of Thyroid Cancer Cells
Authors: Choi Dongwon , Ramu Swapnika , Park Eunkyung , Jung Eunson , Yang Sara , Jung Wonhyeuk , Choi Inho , Lee Sunju , Kim Kyu Eui , Seong Young Jin , Hong Mingu , Daghlian George , Kim Daniel , Shin Eugene , Seo Jung In , Khatchadourian Vicken , Zou Mengchen , Li Wei , De Filippo Roger , Kokorowski Paul , Chang Andy , Kim Steve , Bertoni Ana , Furlanetto Tania Weber , Shin Sung , Li Meng , Chen Yibu , Wong Alex , Koh Chester , Geliebter Jan , Hong Young-Kwon
Published: April 2023

Supplementary Figure Legends
Supplementary Figure S3-6 from Ivermectin Induces Cytostatic Autophagy by Blocking the PAK1/Akt Axis in Breast Cancer
Authors: Dou Qianhui , Chen Hai-Ning , Wang Kui , Yuan Kefei , Lei Yunlong , Li Kai , Lan Jiang , Chen Yan , Huang Zhao , Xie Na , Zhang Lu , Xiang Rong , Nice Edouard C. , Wei Yuquan , Huang Canhua
Published: April 2023

Supplementary Figure S3-6
Supplementary methods and supplementary figure legends from Abscopal Effects of Radiotherapy Are Enhanced by Combined Immunostimulatory mAbs and Are Dependent on CD8 T Cells and Crosspriming
Authors: Rodriguez-Ruiz María E. , Rodriguez Inmaculada , Garasa Saray , Barbes Benigno , Solorzano Jose Luis , Perez-Gracia Jose Luis , Labiano Sara , Sanmamed Miguel F. , Azpilikueta Arantza , Bolaños Elixabet , Sanchez-Paulete Alfonso R. , Aznar M. Angela , Rouzaut Ana , Schalper Kurt A. , Jure-Kunkel Maria , Melero Ignacio
Published: April 2023

supplementary figure legends and supplementary material and methods section.
Supplementary figure 6 from Abscopal Effects of Radiotherapy Are Enhanced by Combined Immunostimulatory mAbs and Are Dependent on CD8 T Cells and Crosspriming
Authors: Rodriguez-Ruiz María E. , Rodriguez Inmaculada , Garasa Saray , Barbes Benigno , Solorzano Jose Luis , Perez-Gracia Jose Luis , Labiano Sara , Sanmamed Miguel F. , Azpilikueta Arantza , Bolaños Elixabet , Sanchez-Paulete Alfonso R. , Aznar M. Angela , Rouzaut Ana , Schalper Kurt A. , Jure-Kunkel Maria , Melero Ignacio
Published: April 2023

Ex-vivo irradiation of human carcinoma surgical expecimens gives rise to more intense expression of CD137 and PD-1 on infiltrating lymphocytes.
Supplementary Materials and Methods from Histone Deacetylase Inhibition in Prostate Cancer Triggers miR-320–Mediated Suppression of the Androgen Receptor
Authors: Sato Shinya , Katsushima Keisuke , Shinjo Keiko , Hatanaka Akira , Ohka Fumiharu , Suzuki Shugo , Naiki-Ito Aya , Soga Norihito , Takahashi Satoru , Kondo Yutaka
Published: April 2023

Additional information of Materials and Methods.
Supplementary figure 4 from Abscopal Effects of Radiotherapy Are Enhanced by Combined Immunostimulatory mAbs and Are Dependent on CD8 T Cells and Crosspriming
Authors: Rodriguez-Ruiz María E. , Rodriguez Inmaculada , Garasa Saray , Barbes Benigno , Solorzano Jose Luis , Perez-Gracia Jose Luis , Labiano Sara , Sanmamed Miguel F. , Azpilikueta Arantza , Bolaños Elixabet , Sanchez-Paulete Alfonso R. , Aznar M. Angela , Rouzaut Ana , Schalper Kurt A. , Jure-Kunkel Maria , Melero Ignacio
Published: April 2023

A course of radiotherapy plus immunostimulatory monoclonal antibodies anti-CD137 and anti-PD-1 mAb increases CD4 and CD8 T cells in the tumor infiltrate as well as the number of tumor antigen-specific CD8 T cells.
Supplementary Figures S1-S7 from Histone Deacetylase Inhibition in Prostate Cancer Triggers miR-320–Mediated Suppression of the Androgen Receptor
Authors: Sato Shinya , Katsushima Keisuke , Shinjo Keiko , Hatanaka Akira , Ohka Fumiharu , Suzuki Shugo , Naiki-Ito Aya , Soga Norihito , Takahashi Satoru , Kondo Yutaka
Published: April 2023

Supplementary Fig. S1. Effect of OBP-801 and other HDAC inhibitors in prostate cancer cells. Supplementary Fig. S2. Western blot analysis of prostate cancer cells treated with OBP-801 or other HDAC inhibitors. Supplementary Fig. S3. Expression analysis of miR-320a, miR-320c, and miR-3065 in prostate cancer cells treated with OBP-801. Supplementary Fig. S4. Luciferase assay of AR 3'UTR with deletion or mutation in miR-320atarget sites. Supplementary Fig. S5. Inhibition of tumor growth and AR expression by OBP-801 in the 22Rv1 xenograft model. Supplementary Fig. S6. Predicted binding sites of rat miR-320aare indicated (arrowheads) in the rat Ar3'-UTR. Supplementary Fig. S7. Effects of combination therapies of OBP-801 and other conventional anti-androgen or chemotherapeutic agents in prostate cancer cell lines.
Supplementary Methods from Androgen Receptor Upregulation Mediates Radioresistance after Ionizing Radiation
Authors: Spratt Daniel E. , Evans Michael J. , Davis Brian J. , Doran Michael G. , Lee Man Xia , Shah Neel , Wongvipat John , Carnazza Kathryn E. , Klee George G. , Polkinghorn William , Tindall Donald J. , Lewis Jason S. , Sawyers Charles L.
Published: April 2023

Supplementary Methods Additional methodology of experimental methods.
Supplementary Figure Legend from Endothelial Side Population Cells Contribute to Tumor Angiogenesis and Antiangiogenic Drug Resistance
Authors: Naito Hisamichi , Wakabayashi Taku , Kidoya Hiroyasu , Muramatsu Fumitaka , Takara Kazuhiro , Eino Daisuke , Yamane Keitaro , Iba Tomohiro , Takakura Nobuyuki
Published: April 2023

Supplementary figure legend for supplementary figure S1
Supplementary Video 3 from Eritoran Suppresses Colon Cancer by Altering a Functional Balance in Toll-like Receptors That Bind Lipopolysaccharide
Authors: Kuo Wei-Ting , Lee Tsung-Chun , Yu Linda Chia-Hui
Published: April 2023

Time lapse imaging of mouse tumor spheroid growth after exposure to LPS and eritoran (1 μg/ml) for 48 h.
Supplementary Materials and Methods from Eritoran Suppresses Colon Cancer by Altering a Functional Balance in Toll-like Receptors That Bind Lipopolysaccharide
Authors: Kuo Wei-Ting , Lee Tsung-Chun , Yu Linda Chia-Hui
Published: April 2023

Detailed information of materials and methods
Supplementary Figure 4 from Eritoran Suppresses Colon Cancer by Altering a Functional Balance in Toll-like Receptors That Bind Lipopolysaccharide
Authors: Kuo Wei-Ting , Lee Tsung-Chun , Yu Linda Chia-Hui
Published: April 2023

TLR2-induced signaling pathways and epithelial proliferation are inhibited by eritoran in Caco-2 cells.
Supplementary Figure 3 from Eritoran Suppresses Colon Cancer by Altering a Functional Balance in Toll-like Receptors That Bind Lipopolysaccharide
Authors: Kuo Wei-Ting , Lee Tsung-Chun , Yu Linda Chia-Hui
Published: April 2023

LPS and eritoran trigger apoptosis in HT29 and Caco-2 cells in a TLR4-independent manner.
Supplementary Dataset 1 from Distinct Subtypes of Gastric Cancer Defined by Molecular Characterization Include Novel Mutational Signatures with Prognostic Capability
Authors: Li Xiangchun , Wu William K.K. , Xing Rui , Wong Sunny H. , Liu Yuexin , Fang Xiaodong , Zhang Yanlin , Wang Mengyao , Wang Jiaqian , Li Lin , Zhou Yong , Tang Senwei , Peng Shaoliang , Qiu Kunlong , Chen Longyun , Chen Kexin , Yang Huanming , Zhang Wei , Chan Matthew T.V. , Lu Youyong , Sung Joseph J.Y. , Yu Jun
Published: April 2023

Clinical data of gastric cancer patients whose genomic data was aggregrated for integrated analysis.
Supplementary Figure 1 from Eritoran Suppresses Colon Cancer by Altering a Functional Balance in Toll-like Receptors That Bind Lipopolysaccharide
Authors: Kuo Wei-Ting , Lee Tsung-Chun , Yu Linda Chia-Hui
Published: April 2023

Intravenous administration of eritoran decreases colon tumor growth in a dose-dependent manner.
Supplementary Table S2 from TG2 and NF-κB Signaling Coordinates the Survival of Mantle Cell Lymphoma Cells via IL6-Mediated Autophagy
Authors: Zhang Han , Chen Zheng , Miranda Roberto N. , Medeiros L. Jeffrey , McCarty Nami
Published: April 2023

Clinical features of the MCL patients.
Supplementary Table S2 from Novel Protein Disulfide Isomerase Inhibitor with Anticancer Activity in Multiple Myeloma
Authors: Vatolin Sergei , Phillips James G. , Jha Babal K. , Govindgari Shravya , Hu Jennifer , Grabowski Dale , Parker Yvonne , Lindner Daniel J. , Zhong Fei , Distelhorst Clark W. , Smith Mitchell R. , Cotta Claudiu , Xu Yan , Chilakala Sujatha , Kuang Rebecca R. , Tall Samantha , Reu Frederic J.
Published: April 2023

Mass spectrometric analysis of proteins that bound to B-CCF642 in MM1.S cells
Supplementary Figure S1 from Novel Protein Disulfide Isomerase Inhibitor with Anticancer Activity in Multiple Myeloma
Authors: Vatolin Sergei , Phillips James G. , Jha Babal K. , Govindgari Shravya , Hu Jennifer , Grabowski Dale , Parker Yvonne , Lindner Daniel J. , Zhong Fei , Distelhorst Clark W. , Smith Mitchell R. , Cotta Claudiu , Xu Yan , Chilakala Sujatha , Kuang Rebecca R. , Tall Samantha , Reu Frederic J.
Published: April 2023

Structure, H-NMR and HRMS of CCF642, B-CCF642 and CCF642-COOH
Supplementary Figure Legends from GON4L Drives Cancer Growth through a YY1–Androgen Receptor–CD24 Axis
Authors: Agarwal Neeraj , Dancik Garrett M. , Goodspeed Andrew , Costello James C. , Owens Charles , Duex Jason E. , Theodorescu Dan
Published: April 2023

Legends for supplementary figures
Supplementary Figure and Table Legends from Antitumor Properties of an IgG2-Enhanced Next-Generation MET Monoclonal Antibody That Degrades Wild-Type and Mutant MET Receptors
Authors: Yang Yan , Mandiyan Sreekala , Robinson Brett S. , McMahon Gerald
Published: April 2023

Legends for Supplementary Figures S1-S4 and Supplementary Table S1.
Supplemental figure 3 from An Imbalance in TAZ and YAP Expression in Hepatocellular Carcinoma Confers Cancer Stem Cell–like Behaviors Contributing to Disease Progression
Authors: Hayashi Hiromitsu , Higashi Takaaki , Yokoyama Naomi , Kaida Takayoshi , Sakamoto Keita , Fukushima Yukiko , Ishimoto Takatsugu , Kuroki Hideyuki , Nitta Hidetoshi , Hashimoto Daisuke , Chikamoto Akira , Oki Eiji , Beppu Toru , Baba Hideo
Published: April 2023

Effects of YAP overexpression on phosphorylation of Erk1/2 in HuH1 cells.
Suppl. Figure 8 from HSP70 Inhibition Limits FAK-Dependent Invasion and Enhances the Response to Melanoma Treatment with BRAF Inhibitors
Authors: Budina-Kolomets Anna , Webster Marie R. , Leu Julia I-Ju , Jennis Matthew , Krepler Clemens , Guerrini Anastasia , Kossenkov Andrew V. , Xu Wei , Karakousis Giorgos , Schuchter Lynn , Amaravadi Ravi K. , Wu Hong , Yin Xiangfan , Liu Qin , Lu Yiling , Mills Gordon B. , Xu Xiaowei , George Donna L. , Weeraratna Ashani T. , Murphy Maureen E.
Published: April 2023

Melanoma cell lines with acquired resistance to BRAF inhibitors Cell viability analysis of the Yumm1.7 and WM983 melanoma cells treated with DMSO or the indicated doses of PLX4032 for 72 hours.
Suppl. Figure 5 from HSP70 Inhibition Limits FAK-Dependent Invasion and Enhances the Response to Melanoma Treatment with BRAF Inhibitors
Authors: Budina-Kolomets Anna , Webster Marie R. , Leu Julia I-Ju , Jennis Matthew , Krepler Clemens , Guerrini Anastasia , Kossenkov Andrew V. , Xu Wei , Karakousis Giorgos , Schuchter Lynn , Amaravadi Ravi K. , Wu Hong , Yin Xiangfan , Liu Qin , Lu Yiling , Mills Gordon B. , Xu Xiaowei , George Donna L. , Weeraratna Ashani T. , Murphy Maureen E.
Published: April 2023

Impact of PET-16 on melanoma in vivo A. Cell viability analysis of B16-F10 cell line treated with DMSO or the indicated doses of PES-Cl or PET-16 for 72 hours.
Suppl. Figure 3 from HSP70 Inhibition Limits FAK-Dependent Invasion and Enhances the Response to Melanoma Treatment with BRAF Inhibitors
Authors: Budina-Kolomets Anna , Webster Marie R. , Leu Julia I-Ju , Jennis Matthew , Krepler Clemens , Guerrini Anastasia , Kossenkov Andrew V. , Xu Wei , Karakousis Giorgos , Schuchter Lynn , Amaravadi Ravi K. , Wu Hong , Yin Xiangfan , Liu Qin , Lu Yiling , Mills Gordon B. , Xu Xiaowei , George Donna L. , Weeraratna Ashani T. , Murphy Maureen E.
Published: April 2023

RPPA Analysis of Melanoma cell lines treated with PET-16 WM793 and 1205Lu cells were treated with DMSO or with the indicated concentrations of PET-16 for 24 hours and then subjected to RPPA analysis.
Supplementary Figure 1 from Low-Dose Paclitaxel Reduces S100A4 Nuclear Import to Inhibit Invasion and Hematogenous Metastasis of Cholangiocarcinoma
Authors: Cadamuro Massimiliano , Spagnuolo Gaia , Sambado Luisa , Indraccolo Stefano , Nardo Giorgia , Rosato Antonio , Brivio Simone , Caslini Chiara , Stecca Tommaso , Massani Marco , Bassi Nicolò , Novelli Eugenio , Spirli Carlo , Fabris Luca , Strazzabosco Mario
Published: April 2023

Supplementary Figure 1. Schedule of treatment with low dose metronomic PTX and assessment by bioluminescence analysis in SCID mice xenografted with EGI-1 cells.
Supplementary Tables S1-S3 from Merlin/NF2 Suppresses Pancreatic Tumor Growth and Metastasis by Attenuating the FOXM1-Mediated Wnt/β-Catenin Signaling
Authors: Quan Ming , Cui Jiujie , Xia Tian , Jia Zhiliang , Xie Dacheng , Wei Daoyan , Huang Suyun , Huang Qian , Zheng Shaojiang , Xie Keping
Published: April 2023

Clinicopathologic characteristics of PDA TMA (S1); Merlin expression and clinicopathologic characteristics of TMA (S2); Nuclear Merlin expression and clinicopathologic characteristics of TMA (S3).
Figure S2 from Inactivation of Cancer-Associated-Fibroblasts Disrupts Oncogenic Signaling in Pancreatic Cancer Cells and Promotes Its Regression
Authors: Dauer Patricia , Zhao Xianda , Gupta Vineet K. , Sharma Nikita , Kesh Kousik , Gnamlin Prisca , Dudeja Vikas , Vickers Selwyn M. , Banerjee Sulagna , Saluja Ashok
Published: April 2023

Quantitation of staining
Supplementary Figure Legends from Merlin/NF2 Suppresses Pancreatic Tumor Growth and Metastasis by Attenuating the FOXM1-Mediated Wnt/β-Catenin Signaling
Authors: Quan Ming , Cui Jiujie , Xia Tian , Jia Zhiliang , Xie Dacheng , Wei Daoyan , Huang Suyun , Huang Qian , Zheng Shaojiang , Xie Keping
Published: April 2023

Legends for Supplementary Figures S1-S7.
Figure S1 from Inactivation of Cancer-Associated-Fibroblasts Disrupts Oncogenic Signaling in Pancreatic Cancer Cells and Promotes Its Regression
Authors: Dauer Patricia , Zhao Xianda , Gupta Vineet K. , Sharma Nikita , Kesh Kousik , Gnamlin Prisca , Dudeja Vikas , Vickers Selwyn M. , Banerjee Sulagna , Saluja Ashok
Published: April 2023

Viability and proliferation of tumor epithelial cells with CAFs